25.11.2024 – 13:52Helmholtz Zentrum MünchenInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
17.10.2022 – 18:21Helmholtz Zentrum MünchenType 1 diabetes: New findings on the development of the autoimmune disease in childrenIDF Websitemehr
27.04.2020 – 17:22Helmholtz Zentrum München2Beta cells from stem cells: Potential for cell replacement therapyRead the studymehr
